Montelukast Prescribing at CREDAS MEDICAL
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,153
Total Quantity
27.8K
NHS Cost
£1.4K
vs National Avg
+68.4%
CREDAS MEDICAL prescribed 1,153 items of Montelukast over the last 12 months at a cost of £1,377 to the NHS. This is 68.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
90
Jul 2026
94
Jul 2026
94
Jul 2026
91
Jul 2026
90
Jul 2026
104
Jul 2026
90
Jul 2026
103
Jul 2026
97
Jul 2026
92
Jul 2026
99
Jul 2026
109
Prescribing Details
| Total Items | 1,153 |
|---|---|
| Total Quantity | 27,839 |
| Total NHS Cost | £1,377 |
| Presentations | 4 different forms |
| vs National Average | +68.4% |
Montelukast Prescribing Comparison
| This practice | 1,153 items |
|---|---|
| National average per practice | 685 items |
| Difference | +68.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.